CASI PHARMACEUTICALS, INC. Investment Owned, at Cost
CASI PHARMACEUTICALS, INC. (CASIF) had Investment Owned, at Cost of $3.38 million as of 2024-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Notes
us-gaap:InvestmentOwnedAtCost · last filed 2026-05-15
- 2024-12-31: Investment Owned, at Cost $3.38M.
| Period end | Investment Owned, at Cost |
|---|---|
| 2024-12-31 | $3.38M 20-F · filed 2026-05-15 |